Marker Therapeutics Inc
MRKR
NASDAQ
Biotechnology
$1.14
USD
+0.03 (+2.70%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $18.67M
Volume 45.6K
About Marker Therapeutics Inc
The company is headquartered in Houston, Texas and currently employs 5 full-time employees. The company went IPO on 2016-11-08.
CEO
Dr. Juan Vera
HQ
Houston, TEXAS, US
Founded
2016
Employees
5
Quantli Score
8.4
Outperform
Fin. Health
8.1
Profitability
7.6
Growth
9.0
Cash-Flow Q.
8.8
Key Metrics
6 metrics our research team weighs before forming a view on MRKR.
Based on Quantli research · SEC filings · as of Q1 2026
METRIC
VALUE
CHANGE
TREND (3Y)
Revenue Growth (TTM)
-40.2%
-101.2 pp
Gross Margin (TTM)
100.0%
0.0 pp
Operating Margin (TTM)
-386.4%
-133.4 pp
Net Margin (TTM)
-340.8%
-101.7 pp
ROE (TTM)
-79.0%
+9.2 pp
Free Cash Flow (TTM)
$-7.92M
—
Financial Snapshot
Revenue
$3.20M
-40.2%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-10.90M
+14.8%
YoY
Operating Cash Flow
$-7.92M
+37.0%
YoY
Key Statistics
Open
$1.14
Previous Close
$1.11
Day Range
$1.12 - $1.16
52 Week Range
$0.81 - $2.46
Volume
45.6K
Average Volume (10 Days)
50.0K
Dividend Yield
—
Valuation Measurement
Market Cap
$18.67M
P/E Ratio (TTM)
—
P/S Ratio (TTM)
5.84
Price / Book
1.35
Financial Highlights
Profit Margin
-340.8%
Return on Assets
-62.5%
Return on Equity
-79.0%
Revenue (TTM)
$3.20M
Net Income (TTM)
$-10.90M
Diluted EPS (TTM)
-$0.66
Total Cash (MRQ)
$14.92M
Levered FCF (TTM)
$-7.92M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Earnings Calendar
Next Earnings
Estimated Q3 Release
Nov 11
Est. EPS
Adjusted consensus estimate
-$0.28